misonidazole has been researched along with Benign Supratentorial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, PC; Deutsch, M; Green, SB; Mealey, J; Paoletti, P; Ransohoff, J; Robertson, JT; Selker, RG; Shapiro, WR; Strike, TA | 1 |
| Arai, M; Hayakawa, K; Niibe, H; Tamura, M | 1 |
1 trial(s) available for misonidazole and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
Topics: Adolescent; Adult; Aged; Astrocytoma; Carmustine; Combined Modality Therapy; Glioblastoma; Glioma; Humans; Middle Aged; Misonidazole; Multicenter Studies as Topic; Prognosis; Radiotherapy Dosage; Random Allocation; Streptozocin; Supratentorial Neoplasms | 1989 |
1 other study(ies) available for misonidazole and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
[Radiation therapy of adult cerebral glioblastoma:].
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Evaluation Studies as Topic; Female; Glioma; Humans; Male; Methods; Middle Aged; Misonidazole; Radiation-Sensitizing Agents; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate | 1989 |